Summary:
This is a study evaluating the safety and clinical effectiveness of ViaDisc nucleus pulposus allograft for replacement of nucleus tissue in patients with symptomatic degenerated discs. The possible benefits of this clinical study include improvement in pain and function in individuals with chronic discogenic low back pain.
Subjects will be evaluated at baseline and followed through 6 months to establish safety and efficacy of the treatment.
- Be above the age of 18
- Have a BMI < 35
- Chronic low back pain for greater than 6 months
- Tried conservative care (i.e. pain medication, physical therapy, acupuncture, chiropractic care, steroid epidural injections, exercise program, etc.)
- Not had any previous lumbar surgery
- Not received any back injections in the last 3 months
- No implantable devices (i.e. pacemaker, spinal chord stimulator)
- No history of malignancy, autoimmune disease, or neurologic disorders
Qualified Participants May Receive:
This study involves a total of 5 visits at our site including screening, injection day, 1 month, 3 month, and 6 month follow-up. There is no cost to the participant for the investigational product, office visits, examinations, and laboratory tests that are required by the study. A $75 gift card will be given at every visit for your time and committment, for a total of $375.